567 related articles for article (PubMed ID: 34357010)
1. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
[TBL] [Abstract][Full Text] [Related]
2. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
3. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
4. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
5. Roles of bioactive sphingolipids in cancer biology and therapeutics.
Saddoughi SA; Song P; Ogretmen B
Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
[TBL] [Abstract][Full Text] [Related]
6. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell growth, survival and migration by ceramide 1-phosphate - implications in lung cancer progression and inflammation.
Gomez-Larrauri A; Ouro A; Trueba M; Gomez-Muñoz A
Cell Signal; 2021 Jul; 83():109980. PubMed ID: 33727076
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid targets in cancer therapy.
Modrak DE; Gold DV; Goldenberg DM
Mol Cancer Ther; 2006 Feb; 5(2):200-8. PubMed ID: 16505092
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
11. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
12. Ceramide 1-phosphate/ceramide, a switch between life and death.
Gómez-Muñoz A
Biochim Biophys Acta; 2006 Dec; 1758(12):2049-56. PubMed ID: 16808893
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ceramide Kinase Is Effective against Cisplatin-Resistant Ovarian Cancer Cells by Regulating Ceramide and C1P Levels.
Zou J; Jian L
Gynecol Obstet Invest; 2023; 88(1):61-70. PubMed ID: 36682357
[TBL] [Abstract][Full Text] [Related]
14. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling aspects of ceramide 1-phosphate.
Presa N; Gomez-Larrauri A; Dominguez-Herrera A; Trueba M; Gomez-Muñoz A
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158630. PubMed ID: 31958571
[TBL] [Abstract][Full Text] [Related]
16. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
[TBL] [Abstract][Full Text] [Related]
17. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
Ekiz HA; Baran Y
Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
[TBL] [Abstract][Full Text] [Related]
18. Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C; Norris JS; White-Gilbertson S
Adv Cancer Res; 2018; 140():265-293. PubMed ID: 30060812
[TBL] [Abstract][Full Text] [Related]
19. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
Dagan A; Wang C; Fibach E; Gatt S
Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
[TBL] [Abstract][Full Text] [Related]
20. The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis.
Hinkovska-Galcheva V; VanWay SM; Shanley TP; Kunkel RG
Curr Opin Investig Drugs; 2008 Nov; 9(11):1192-205. PubMed ID: 18951299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
